Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.14 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sangamo Therapeutics, Inc (SGMOQ) EBITDA (2010 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) reported EBITDA of -$37.21 million for Q4 2025, compared with -$24.75 million a year earlier.

Analysis

Sangamo Therapeutics, Inc (SGMOQ) EBITDA (2010 - 2025) Analysis & Trends

For FY2025, Sangamo Therapeutics posted EBITDA of -$117.24 million.

  • By year, EBITDA came in at -$98.86 million in FY2024, -$258.91 million in FY2023, -$189.17 million in FY2022 and -$173.9 million in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly EBITDA since Q1 2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at -$34.56 million (Q3 2025), -$16.86 million (Q2 2025) and -$28.61 million (Q1 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -37.21 Mn
Sep 30, 2025 -34.56 Mn
Jun 30, 2025 -16.86 Mn
Mar 31, 2025 -28.61 Mn
Dec 31, 2024 -24.75 Mn
Sep 30, 2024 11.85 Mn
Jun 30, 2024 -35.84 Mn
Mar 31, 2024 -50.12 Mn
Dec 31, 2023 -60.20 Mn
Sep 30, 2023 -100.92 Mn
Jun 30, 2023 -119.32 Mn
Mar 31, 2023 21.52 Mn
Dec 31, 2022 -52.05 Mn
Sep 30, 2022 -51.85 Mn
Jun 30, 2022 -42.85 Mn
Mar 31, 2022 -42.43 Mn
Dec 31, 2021 -37.14 Mn
Sep 30, 2021 -45.88 Mn
Jun 30, 2021 -46.46 Mn
Mar 31, 2021 -44.43 Mn
API Access

Sangamo Therapeutics, Inc EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY